Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Aurora Cannabis Inc. (OTC: ACBFF).

Full DD Report for ACBFF

You must become a subscriber to view this report.


Recent News from (OTC: ACBFF)

Veterinarians mull marijuana for pets
"There's a tremendous future in [medical marijuana for pets], and I believe as time goes on, they will serve a great use. But, at this point, we're handcuffed." So says a New Jersey veterinarian . "No one wants to take any risk. You don't want to be the pioneer and risk your license." ...
Source: SeekingAlpha
Date: July, 20 2018 11:02
These Marijuana Stocks are Prepared for the End of Cannabis Prohibition
CORAL GABLES, FL / ACCESSWIRE / July 19, 2018 / As Cannabis Prohibition continues to come to an end, there are many marijuana stocks catering to the retail consumer that are flourishing. There are less than 3 months left until the official launch of the sale of legal cannabis in Canada, whic...
Source: ACCESSWIRE IA
Date: July, 19 2018 12:15
Aurora Shareholders Approve Acquisition of MedReleaf and Australis Spin-Out
Aurora Shareholders Approve Acquisition of MedReleaf and Australis Spin-Out Canada NewsWire EDMONTON, July 18, 2018 Combination of Complementary Teams and Assets Creates Industry Leader Positioned for Accelerated Growth TSX: ACB EDMONTON , July 18, 2018 /CNW/ - Auro...
Source: Canada Newswire
Date: July, 18 2018 16:00
ETFMG Alternative Harvest ETF MJ - 2018 Q2 Update
One of the most popular ways for investors to participate in the marijuana sector is through a diversified ETF. Besides the highly popular Canadian marijuana ETFs including the Horizons Marijuana Life Sciences ETF ( OTC:HMLSF ) and the Emerging Marijuana Growers ETF ( OTCPK:HZEMF ), U.S. inv...
Source: SeekingAlpha
Date: July, 18 2018 09:17
Hemp CBD Products Offer a Natural Alternative to Synthetic-Derived Medicines
CannabisNewsWire Editorial Coverage : The opioid crisis in North America has drawn attention to the urgent need for alternative medicines, and hemp CBD products offer a viable plant-based option. An active ingredient in industrial hemp, Cannabidiol (CBD) can be extracted to be used in a ...
Source: CannabisNewsWire
Date: July, 18 2018 09:00
Should Sunniva Spin Off The Canadian Assets?
Sunniva ( OTC:SNNVF ) announced on July 10 that the company will spin off its Canadian assets into a separate entity that will seek a listing on the TSX and Nasdaq. The first reaction from us is that the Sunniva management is getting impatient with its current strategy and clearly is frustra...
Source: SeekingAlpha
Date: July, 17 2018 15:34
The BAK Portfolio: Canadian Weed Is Legal And The Green Rush Has Begun
Legal Weed On June 19, the Canadian Senate passed Bill C-45, legalizing recreational cannabis nationwide. Starting October 17, dispensaries across Canada will be able to sell cannabis to non-medical users. This new recreational market is expected to grow to around $8 billion over the n...
Source: SeekingAlpha
Date: July, 17 2018 09:48
A Cannabis Market Bigger than Canada
Palm Beach FL – July 17, 2018 – The marijuana market has seen some big changes this year.  For example, Canada just passed Bill C-45 (the Cannabis Act), which could add up to $5 billion in annual sales to a budding industry.  Even California, which legalized its use in ea...
Source: MarketNewsUpdates.com
Date: July, 17 2018 08:19
Marijuana Stock Report: One For You, Nineteen For Me
The North American Marijuana Index plummeted on Monday, as pot stocks fell below 200 points following news of Canada’s plans for an “annual regulatory fee” amounting to 2.3 percent on the gross revenues of the country’s biggest Licensed Producers . Industry insid...
Source: Pot News
Date: July, 17 2018 00:03
Weekly Cannabis Report: Alberta Picks 31 Suppliers
Welcome to our Weekly Cannabis Report, a reliable source for cannabis investors to receive the latest developments and analysis. Trading Summary Last week, the widely-tracked Horizons Marijuana Life Sciences Index ETF ( OTC:HMLSF ) traded down 1.6% and ended the week at C$17.95. We recentl...
Source: SeekingAlpha
Date: July, 16 2018 13:47

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-07-205.805.645.865.582,165,590
2018-07-196.125.806.185.762,190,685
2018-07-186.0756.056.185.96930,668
2018-07-176.0356.0236.225.941,924,862
2018-07-166.496.136.576.12032,468,918

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-07-20868,1702,164,89040.1023Short
2018-07-191,167,6212,190,18553.3115Short
2018-07-18293,974930,48231.5937Cover
2018-07-17481,4351,921,50125.0552Cover
2018-07-16740,9942,467,41730.0312Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ACBFF.


About Aurora Cannabis Inc. (OTC: ACBFF)

Logo for Aurora Cannabis Inc. (OTC: ACBFF)

Aurora s wholly owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada s Access to Cannabis for Medical Purposes Regulations ACMPR . The Company operates a , square foot, state of the art production facility in Mountain View County, Alberta, known as Aurora Mountain, is currently constructing a second , square foot production facility, known as Aurora Sky , at the Edmonton International Airport, and has acquired, and is undertaking completion of a third , square foot production facility in Pointe Claire, Quebec, on Montreal s West Island. In addition, the Company holds approximately . of the issued shares . on a fully diluted basis in a leading extraction technology company, Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton based Hempco Food and Fiber Inc. for an ownership stake exceeding . . Furthermore, Aurora is the cornerstone investor with a . stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora also owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union EU , based in Germany. Aurora s common shares trade on TSX under the symbol ACB .and on the OTCQX under the symbol ACBFF

 

 

 

Current Management

  • Terry Booth / CEO
  • Steven Dobler / President
  • Allan Cleiren / COO
  • Nilda Rivera / Secretary
  • Cameron Battley / EVP
  • Michael Singer / Chairman, Independent Director, Audit Committee Member
  • Terry Booth / Nominating Committee Member
  • Steven Dobler / Compensation Committee Member
  • Jason Dyck / Independent Director, Nominating Committee Member
  • Joseph Del Moral / Independent Director
  • Adam Szweras / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Current Share Structure

  • Market Cap: $3,288,392,296 - 03/09/2018
  • Issue and Outstanding: 371,569,751 - 09/25/2017

 


Recent Filings from (OTC: ACBFF)

Management Discussion and Analysis - Q2 Dec 31, 2017 MD&A
Filing Type: Management Discussion and Analysis - Q2 Dec 31, 2017 MD&AFiling Source: OTC Markets
Filing Date: February, 08 2018
Interim Financial Report - Q2 Dec 31, 2017 Interim Financial Statements
Filing Type: Interim Financial Report - Q2 Dec 31, 2017 Interim Financial StatementsFiling Source: OTC Markets
Filing Date: February, 08 2018
Management Discussion and Analysis - Q1 Sep 30, 2017 Interim MD&A
Filing Type: Management Discussion and Analysis - Q1 Sep 30, 2017 Interim MD&AFiling Source: OTC Markets
Filing Date: November, 09 2017
Quarterly Report - Q1 Sep 30, 2017 Interim Financial Statements
Filing Type: Quarterly Report - Q1 Sep 30, 2017 Interim Financial StatementsFiling Source: OTC Markets
Filing Date: November, 09 2017
Management Discussion and Analysis - MD&A - Year Ended Jun 30, 2017
Filing Type: Management Discussion and Analysis - MD&A - Year Ended Jun 30, 2017Filing Source: OTC Markets
Filing Date: September, 26 2017
Annual Report - Audited Financial Statements - Year Ended June 30, 2017
Filing Type: Annual Report - Audited Financial Statements - Year Ended June 30, 2017Filing Source: OTC Markets
Filing Date: September, 26 2017
Management Discussion and Analysis - Q3 March 31, 2017 MD&A
Filing Type: Management Discussion and Analysis - Q3 March 31, 2017 MD&AFiling Source: OTC Markets
Filing Date: May, 15 2017
Interim Financial Report - Q3 March 31, 2017 Interim Financial Statements
Filing Type: Interim Financial Report - Q3 March 31, 2017 Interim Financial StatementsFiling Source: OTC Markets
Filing Date: May, 15 2017
Management Discussion and Analysis - Q2 Dec 31, 2016 MD&A
Filing Type: Management Discussion and Analysis - Q2 Dec 31, 2016 MD&AFiling Source: OTC Markets
Filing Date: February, 27 2017
Interim Financial Report - Q2 Dec 31, 2016 FS
Filing Type: Interim Financial Report - Q2 Dec 31, 2016 FSFiling Source: OTC Markets
Filing Date: February, 27 2017

 

 


Daily Technical Chart for (OTC: ACBFF)

Daily Technical Chart for (OTC: ACBFF)


Stay tuned for daily updates and more on (OTC: ACBFF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ACBFF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ACBFF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of ACBFF and does not buy, sell, or trade any shares of ACBFF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/